OBJECTIVE: To examine the evidence guiding management of multiple sclerosis (MS) in
reproductive-aged women. DATA SOURCES: We conducted an electronic literature search …

Bronner G, Elran E, Golomb J, Korczyn AD. Female sexuality in multiple sclerosis: the
multidimensional nature of the problem and the intervention. Acta Neurol Scand: 2010: 121 …

Background Patients with multiple sclerosis (MS) or Crohn's disease (CD) being treated with
natalizumab (Tysabri®, Biogen) who are planning to become pregnant or discover they are …

Objective To determine the rate of relapse occurrence during pregnancy and postpartum.
Methods In a cross-sectional study using the national multiple sclerosis (MS) registry …

Breastfeeding Management for the Clinician: Using the Evidence is the perfect tool for busy
clinicians who need a quick, accurate, and current reference. It provides the essentials of …

Objective: To assess pregnancy and fetal outcomes after in utero exposure to interferon-β
(IFNβ) in all pregnancies occurring in women with multiple sclerosis (MS) during the study …

Objective: To assess the relationship between breastfeeding and risk of puerperal relapses
in a large cohort of patients with multiple sclerosis (MS). Methods: We prospectively followed …

Objective: The objective of this study was to evaluate exposure to disease-modifying
therapies (DMTs) during pregnancy in 335 pregnancies of multiple sclerosis (MS) patients …

Introduction Delayed-release dimethyl fumarate (DMF; also known as gastro-resistant DMF)
is an oral agent for the treatment of relapsing forms of multiple sclerosis (MS). No formal …

The issue of fertility in patients with multiple sclerosis (MS) has not been exhaustively
studied. Epidemiological data have suggested that spontaneous fecundity might be …